MedTrace Logo

Effects of Vojta Therapy on Posture and Trunk Control

NCT07244952 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-11-28

No results posted yet for this study

Summary

Vojta therapy that is reflex locomotion therapy is a neurophysiological rehabilitation approach that stimulates specific "reflex zones" on the body to activate global, innate movement patterns. In stroke rehabilitation, it is used to improve postural control, trunk stability, and functional movement by engaging automatic motor responses. Vojta stimulation can activate motor cortical and subcortical areas as well as postural muscles. Pose estimation will be used to analyze human motion in stroke patients. The study will identify if there is significant difference in the comparative effects of Vojta therapy in addition to routine physical therapy on posture, trunk control and upper extremity motor function in sub-acute stroke patients

Conditions

Interventions

OTHER

Vojta therapy

Vojta therapy will be implemented for reflex rolling and reflex creeping. A small pressure with dorsal, medial and cranial directional stimuli will be provided. After stimulation the reactions are extension of spine, flexion of hip joint, then knee joint and in the end at ankle joint. 5 sessions per week with a 60-minute session are part of protocol for routine physical therapy and vojta therapy for 8 weeks.

OTHER

Routine physical therapy

The control group will receive routine physical therapy treatment which will consist of positioning, passive movements of the limbs, sensorimotor exercises for the affected limb using task-oriented training and motor relearning program consisting of repetitive motor skills consisting of functional tasks and involves task breakdown, such as transfers, upper limb function will be performed. 5 sessions per week with a 60-minute session are part of protocol for routine physical therapy and core stability for 8 weeks.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-15
Primary Completion
2026-08-15
Completion
2026-08-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07244952 on ClinicalTrials.gov